Literature DB >> 31113769

Anticoagulant-Related Nephropathy: It's the Real McCoy.

Richard J Glassock1.   

Abstract

Entities:  

Keywords:  Acute Kidney Injury; Anti-Coagulant; Anticoagulants; Kidney Diseases; Warfarin; chronic kidney disease

Year:  2019        PMID： 31113769      PMCID： PMC6556734          DOI： 10.2215/CJN.02470319

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.

Authors:  Kyle Ware; Polina Brodsky; Anjali A Satoskar; Tibor Nadasdy; Gyongyi Nadasdy; Haifeng Wu; Brad H Rovin; Udayan Bhatt; Jon Von Visger; Lee A Hebert; Sergey V Brodsky
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

Review 2.  Anticoagulant-Related Nephropathy.

Authors:  Sergey Brodsky; John Eikelboom; Lee A Hebert
Journal:  J Am Soc Nephrol       Date:  2018-11-12       Impact factor: 10.121

3.  Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.

Authors:  Margaret Ryan; Kyle Ware; Zahida Qamri; Anjali Satoskar; Haifeng Wu; Gyongyi Nadasdy; Brad Rovin; Lee Hebert; Tibor Nadasdy; Sergey V Brodsky
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

4.  Anticoagulant-related nephropathy: a pathological note.

Authors:  Vincenzo L'Imperio; Alessia Guarnieri; Federico Pieruzzi; Renato Alberto Sinico; Fabio Pagni
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

5.  Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Authors:  Sergey V Brodsky; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Gyongyi M Nadasdy; Haifeng M Wu; Udayan Y Bhatt; Lee A Hebert
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

6.  Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study.

Authors:  Siavash Piran; Hugh Traquair; Noel Chan; Marlene Robinson; Sam Schulman
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

Review 7.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

8.  Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

Authors:  Sergey V Brodsky; Anjali Satoskar; Jun Chen; Gyongyi Nadasdy; Jeremiah W Eagen; Mirza Hamirani; Lee Hebert; Edward Calomeni; Tibor Nadasdy
Journal:  Am J Kidney Dis       Date:  2009-07-04       Impact factor: 8.860

9.  Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile.

Authors:  Vittorio Di Maso; Michele Carraro; Elena Bevilacqua; Sergio Bucconi; Mary Louise Artero; Giuliano Boscutti
Journal:  Clin Kidney J       Date:  2014-10-28
  9 in total
  11 in total

Review 1.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

2.  Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury.

Authors:  Benedikt Kolbrink; Friedrich Alexander von Samson-Himmelstjerna; Maja Lucia Messtorff; Theresa Riebeling; Raphael Nische; Jessica Schmitz; Jan Hinrich Bräsen; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Cell Mol Life Sci       Date:  2022-06-28       Impact factor: 9.207

3.  IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.

Authors:  Hernando Trujillo; Justo Sandino; Teresa Cavero; Fernando Caravaca-Fontán; Eduardo Gutiérrez; Ángel M Sevillano; Amir Shabaka; Gema Fernández-Juárez; Pablo Rodríguez Doyágüez; Rocío Gimena Muñoz; Leonardo Calle García; Virginia Cabello; José Manuel Muñoz-Terol; Ana García Santiago; Oscar Toldos; Juan Antonio Moreno; Manuel Praga
Journal:  Kidney Int Rep       Date:  2022-01-19

4.  Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET.

Authors:  Elvira Grandone; Filippo Aucella; Doris Barcellona; Giuliano Brunori; Giacomo Forneris; Paolo Gresele; Marco Marietta; Daniela Poli; Sophie Testa; Armando Tripodi; Simonetta C Genovesi
Journal:  Blood Transfus       Date:  2020-08-06       Impact factor: 3.443

5.  Anticoagulant strategies for the patient with chronic kidney disease.

Authors:  Jonathan P Law; Luke Pickup; Jonathan N Townend; Charles J Ferro
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

Review 6.  Non-immunosuppressive therapies for childhood IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2021-02-16       Impact factor: 3.714

Review 7.  An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy.

Authors:  Ron Hogg
Journal:  Pediatr Nephrol       Date:  2021-05-13       Impact factor: 3.714

Review 8.  Narrative Review of Hypercoagulability in Small-Vessel Vasculitis.

Authors:  Sophie E Claudel; Bryan M Tucker; Daniel T Kleven; James L Pirkle; Mariana Murea
Journal:  Kidney Int Rep       Date:  2020-01-13

9.  Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).

Authors:  Elvira Grandone; Filippo Aucella; Doris Barcellona; Giuliano Brunori; Giacomo Forneris; Paolo Gresele; Marco Marietta; Daniela Poli; Sophie Testa; Armando Tripodi; Simonetta Genovesi
Journal:  J Nephrol       Date:  2020-07-31       Impact factor: 3.902

10.  Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study.

Authors:  Justin Y Lu; Wei Hou; Tim Q Duong
Journal:  Infection       Date:  2021-06-26       Impact factor: 7.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.